| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Erlotinib^24H post dose | LP437669-7 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| METHOD_TYP | LC/MS/MS | LP95062-3 |
| parent | Erlotinib | Serum or Plasma | Drug toxicology | LP440650-2 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ug/L | |
| EXAMPLE_UCUM_UNITS | ug/L | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | Erlotinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| LONG_COMMON_NAME | en-US | Erlotinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose |
| SHORTNAME | en-US | Erlotinib 24h p SerPl LC/MS/MS-mCnc |
| ConsumerName | en-US | Erlotinib 24 hr after dose, Blood |
| LONG_COMMON_NAME | fr-FR | Erlotinib T24h après administration [Masse/Volume] Sérum/Plasma ; Numérique ; LC/MS/MS |
| LONG_COMMON_NAME | nl-NL | Erlotinib^24 uur na dosis [massa/volume] in serum of plasma d.m.v. LC/MS/MS |
LOINC Version: 2.80
FHIR